Production of an interleukin-10 blocking antibody by genetically engineered macrophages increases cancer cell death in human gastrointestinal tumor slice cultures.

MLA

Labadie, Kevin P., et al. “Production of an Interleukin-10 Blocking Antibody by Genetically Engineered Macrophages Increases Cancer Cell Death in Human Gastrointestinal Tumor Slice Cultures.” Cancer Gene Therapy, vol. 30, no. 9, Sept. 2023, pp. 1227–33. EBSCOhost, https://doi.org/10.1038/s41417-023-00632-z.

APA

Labadie, K. P., Kreuser, S. A., Brempelis, K. J., Daniel, S. K., Jiang, X., Sullivan, K. M., Utria, A. F., Kenerson, H. L., Kim, T. S., Crane, C. A., & Pillarisetty, V. G. (2023). Production of an interleukin-10 blocking antibody by genetically engineered macrophages increases cancer cell death in human gastrointestinal tumor slice cultures. Cancer Gene Therapy, 30(9), 1227–1233. https://doi.org/10.1038/s41417-023-00632-z

Chicago

Labadie, Kevin P, Shannon A Kreuser, Katherine J Brempelis, Sara K Daniel, Xiuyun Jiang, Kevin M Sullivan, Alan F Utria, et al. 2023. “Production of an Interleukin-10 Blocking Antibody by Genetically Engineered Macrophages Increases Cancer Cell Death in Human Gastrointestinal Tumor Slice Cultures.” Cancer Gene Therapy 30 (9): 1227–33. doi:10.1038/s41417-023-00632-z.